PATENT CLAIM ANALYSIS

Application Number: 15903635
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "130100"]

Abstract:
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include low-molecular-weight and/or high-molecular-weight proteins, such as mAbs, and viscosity-lowering agents that are typically bulky polar organic compounds, such as many of the GRAS (US Food and Drug Administration List of compounds generally regarded as safe) and inactive injectable ingredients and FDA approved therapeutics.

Claim (Index 3):
The liquid composition of  claim 1 , wherein the solvent is aqueous.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.31818
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15903523', '14484160', '14483896', '14483880', '15542921']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8332681502459113
- 35 USC 102 Novelty (BERT): 0.6694499255968884
- Combined Prediction Score: 0.816886327781009
- Mean Citation Score: 513.5305400000002
- Max Citation Score: 655.7298
- Similarity Product: 645.0206355474471

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test